Muss man wirklich auch die letzte Krebszelle eliminieren?

1 Simone JV. The treatment of acute lymphoblastic leukaemia. Br J Haematol. 1980;45(1):1-4; https://doi.org/10.1111/j.1365-2141.1980.tb03804.x

2 Saygin C et al. Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. Haematologica 2022;107(12):2783–2793; https://doi.org/10.3324/haematol.2022.280638

3 Blachly JS et al. The present and future of measurable residual disease testing in acute myeloid leukemia. Haematologica 2022;107(12):2810-2822; https://doi.org/10.3324/haematol.2022.282034

4 Chin-Yee B et al. Epistemic limitations of measurable residual disease in haematological malignancies. Lancet Haematol. 2025;12(3):e224-e229; https://doi.org/10.1016/s2352-3026(25)00002-x

5 Mateos MV, Puig N. Accelerating Myeloma Drug Development: Will Minimal Residual Disease Replace Progression-Free Survival as an Intermediate Surrogate End Point? J Clin Oncol 2025; https://doi.org/10.1200/jco-25-00048

6 Shi Q et al. Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials. J Clin Oncol. 2025; https://doi.org/10.1200/jco-24-02020